Edward H. Romond, MD

Dr. Romond is a graduate of University of Kentucky College of Medicine and completed residency and fellowship at Michigan State University in East Lansing.

He is certified by the American Board of Internal Medicine, American Board of Internal Medicine, Hematology, and American Board of Internal Medicine, Medical Oncology. He received the Leonard Tow 2003 Humanism in Medicine Award.

Dr. Romond has been the principal investigator for the National Surgical Adjuvant Breast and Bowel Project (NSABP) adjubant studies at the University of Kentucky since 1985. He currently serves on the Board of Directors of the NSABP Foundation and is the Chair of the NSABP Membership Committee. He is the protocol chair for NSABP B-31, one of the landmark studies that demonstrated the efficacy of trastuzumab in the adjuvant treatment of HER2-positive breast cancer. He also serves as the Medical Director for the Markey Cancer Center Genetics Counseling Program.

Clinical interests include Adult Hemophilia, Breast Cancer, and Medical Oncology.